The costs at a glance
| Published price reference | $175/month Month-to-month compounded semaglutide plan |
|---|---|
| Medication | Compounded semaglutide and tirzepatide standard plans; separate microdose options |
| Commitment | Monthly, quarterly, six-month and annual auto-renewing plans; shipment and refund rules vary |
| Important context | Annual semaglutide $1,188 upfront ($99/month equivalent); quarterly $435; six-month $720. Early long-plan refunds reprice received supply at quarterly rates; prepared shipments nonrefundable. |
Plans and purchase options
Monthly semaglutide
$175 billed monthly
Compare against full annual commitment, not only its equivalent.
Annual semaglutide
$1,188 upfront; $99/month equivalent
Early refund reprices received supply at quarterly rates.
Monthly tirzepatide
$225 billed monthly
Annual $1,620 is a different term and upfront amount.
Cora’s main decision is how much to prepay
Cora Health offers compounded GLP-1 plans with several purchase terms, from month to month to annual. The lowest displayed monthly equivalent belongs to a larger upfront commitment, so I would not make it the default comparison for a reader seeking flexibility. Start by deciding how much uncertainty you are comfortable financing before comparing discounts. The clinical plan can change, and a prepaid purchase does not guarantee that the same prescription remains appropriate throughout the term. Cora’s detailed refund policy helps explain that tradeoff, but its calculations need to be understood before the annual price is treated as a simple saving.
Semaglutide is $175 monthly or $1,188 annually
Cora’s standard semaglutide page lists $175 for month-to-month service, $435 per quarter, $720 for six months and $1,188 for twelve months. The annual equivalent is $99 monthly, but the charge is for the full annual term. The stated scope includes provider consultation, medication when prescribed, shipping and monitoring. I would compare the total collected and the renewal interval, then confirm the exact preparation and dose covered. A lower equivalent does not mean the patient can cancel after one month and retain the annual discount. That is where the refund rules become part of the value calculation. For a closer look, read our total GLP-1 cost guide.
Tirzepatide has its own plan ladder
The standard tirzepatide page lists $225 month to month, $597 per quarter, $1,050 for six months and $1,620 annually. The annual equivalent is $135 monthly, and it should remain attached to its twelve-month payment. These plans should not be confused with Cora’s separately described fixed-dose microdose offerings, which have different pricing and clinical goals. I would ask the clinician which program is being considered and what evidence supports that regimen. Readers should not move between product categories in a comparison simply to use the lowest displayed number; the actual medication, dose and care arrangement need to stay consistent.
Shipping runs on a different schedule from annual billing
Cora’s refund policy says monthly plans ship monthly, quarterly plans ship as one three-month supply, and six- and twelve-month plans ship in three-month batches. That is important because a payment term is not the same as one shipment or one vial’s usable life. Ask when each future batch is prepared and what clinical review occurs before release. I would also confirm the pharmacy’s labeled storage and beyond-use instructions for the actual preparation. A plan can spread deliveries across the year while still collecting the full annual charge upfront, leaving a different financial exposure from a monthly purchase. For a closer look, read our medication shipping and handling guide.
An early refund recalculates what you already received
For six- and twelve-month plans, Cora says received doses are repriced at the listed quarterly rate for the same medication when an eligible refund is calculated. The remaining amount is then refunded, rather than simply dividing the annual payment by twelve and returning unused months. This can materially reduce the savings of leaving early. I would ask for an example using the selected medicine and shipment schedule before prepaying. The policy says the customer is not charged more than originally paid, but that does not make the refund a simple pro-rata balance or guarantee that much remains after several batches have been prepared. For a closer look, read our refund and cancellation guide.
Preparation can end a shipment’s refundability
The policy says a supply cannot be returned or refunded once the pharmacy has prepared and labeled it. A quarterly plan can therefore be fully delivered for refund purposes once its three-month supply is prepared, even before the reader experiences the full treatment period. Cora describes full refunds before the first shipment is prepared or after a provider finds the patient medically ineligible. I would clarify the timing of that decision and where a cancellation request is recorded. A pause also needs an agreed restart date, because the policy describes billing and shipments resuming automatically on that selected date.
The care relationship remains separate from the platform
Cora describes itself as connecting patients with independent licensed clinicians and pharmacy fulfillment. The broad service area does not establish that every preparation is available to every patient, so confirm the actual product and location during evaluation. Ask how follow-up works, who reviews side effects and whether a prescription adjustment changes the supply covered by a prepaid batch. I would also establish how records are transferred if leaving. The annual discount is easier to assess when the clinical process is explicit: patients need to understand how care responds to a changing situation rather than treating a long purchase as a fixed medical plan.
My take: choose the commitment only after understanding the refund math
Cora gives readers unusually clear purchase totals and a substantive prepaid-refund policy. That transparency helps, but the best choice is not automatically the longest term. I would favor the monthly reference point while treatment needs remain uncertain, then compare larger purchases only after the clinical plan and shipment timing are understood. Found offers another continuing-care comparison, while Strut Health provides a different product-specific model. Cora’s value depends on the actual preparation and the term you will realistically complete. The annual equivalent is useful arithmetic, but its savings are conditional on how long the plan continues and what has already been prepared. For a closer look, read our Found review. Also compare our Direct Meds review for a separate look at its actual care and purchase structure.
Before you sign up
- What amount remains refundable after quarterly-rate repricing if I leave my annual plan early?
- When is each three-month batch prepared, and how do I stop the next batch in time?
- Does my selected offer use the standard plan or a different fixed-dose microdose program?
Use the answers to compare the exact offer with another provider. A service review cannot determine whether a medication is appropriate for you; that decision belongs with your clinician.
Compare the complete budget · Save your provider checklist